Free Trial
NASDAQ:BMRA

Biomerica (BMRA) Stock Price, News & Analysis

Biomerica logo
$3.15 -0.19 (-5.69%)
Closing price 07/11/2025 03:46 PM Eastern
Extended Trading
$2.99 -0.16 (-5.08%)
As of 07/11/2025 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Biomerica Stock (NASDAQ:BMRA)

Key Stats

Today's Range
$2.97
$3.28
50-Day Range
$3.03
$3.67
52-Week Range
$1.93
$10.16
Volume
41,740 shs
Average Volume
283,831 shs
Market Capitalization
$8.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biomerica Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

BMRA MarketRank™: 

Biomerica scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Biomerica.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Biomerica is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Biomerica is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Biomerica has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Biomerica's valuation and earnings.
  • Percentage of Shares Shorted

    2.00% of the float of Biomerica has been sold short.
  • Short Interest Ratio / Days to Cover

    Biomerica has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biomerica has recently decreased by 13.37%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Biomerica does not currently pay a dividend.

  • Dividend Growth

    Biomerica does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.00% of the float of Biomerica has been sold short.
  • Short Interest Ratio / Days to Cover

    Biomerica has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biomerica has recently decreased by 13.37%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Biomerica has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Biomerica this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for BMRA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Biomerica to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Biomerica insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.00% of the stock of Biomerica is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 22.28% of the stock of Biomerica is held by institutions.

  • Read more about Biomerica's insider trading history.
Receive BMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter.

BMRA Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

BMRA Stock Analysis - Frequently Asked Questions

Biomerica's stock was trading at $2.4008 at the beginning of 2025. Since then, BMRA stock has increased by 31.2% and is now trading at $3.15.

Biomerica, Inc. (NASDAQ:BMRA) released its earnings results on Monday, April, 14th. The company reported ($0.48) earnings per share for the quarter. The firm earned $1.12 million during the quarter. Biomerica had a negative trailing twelve-month return on equity of 85.90% and a negative net margin of 85.42%.

Biomerica shares reverse split on the morning of Monday, April 21st 2025.The 1-8 reverse split was announced on Wednesday, April 16th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 18th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of BMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biomerica investors own include Pfizer (PFE), Gilead Sciences (GILD), AT&T (T), NIO (NIO), Exxon Mobil (XOM), Avino Silver & Gold Mines (ASM) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
4/14/2025
Today
7/12/2025
Next Earnings (Estimated)
8/26/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BMRA
CIK
73290
Employees
60
Year Founded
1971

Profitability

EPS (Trailing Twelve Months)
($2.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.98 million
Net Margins
-85.42%
Pretax Margin
-85.35%
Return on Equity
-85.90%
Return on Assets
-61.06%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.76
Quick Ratio
2.76

Sales & Book Value

Annual Sales
$5.41 million
Price / Sales
1.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.13 per share
Price / Book
1.01

Miscellaneous

Outstanding Shares
2,550,000
Free Float
2,164,000
Market Cap
$8.03 million
Optionable
Optionable
Beta
0.35

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:BMRA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners